Spravato vs. Antidepressants: Which is Better?
Menu
Spravato Treatment: What You Need to Know
Mental health providers play a critical role in helping patients navigate treatment options for conditions like treatment-resistant depression (TRD). One innovative option gaining attention is esketamine, marketed under the brand name Spravato. This guide will walk you through everything you need to know about providing Spravato services, from understanding the medication to addressing patient concerns and ensuring safe administration.
What is Esketamine (Spravato), and How is it Used?
Esketamine, the active ingredient in Spravato, is a nasal spray derived from ketamine. It is FDA-approved for treating treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts or actions. Unlike traditional antidepressants, which can take weeks to show effects, Spravato works rapidly, often providing relief within hours or days.
Spravato must be administered in a certified medical setting under the supervision of a healthcare provider. Patients self-administer the nasal spray during a clinic visit and are monitored for at least two hours post-dose to ensure safety.
What Are the Side Effects of Esketamine (Spravato)?
Like all medications, Spravato can cause side effects.
Common side effects of Spravato include:
- Dizziness
- Nausea
- Fatigue
- Increased blood pressure
- Dissociation (feeling disconnected from reality)
- Sedation
Serious side effects can include:
- Suicidal thoughts or behaviors
- Blurred vision
- Trouble breathing
Most side effects are mild to moderate and resolve within a few hours. However, providers should educate patients about these potential effects and monitor them closely during and after administration.
What is the Dosage for Esketamine (Spravato)?
The dosage of Spravato varies depending on the treatment phase:
- Induction Phase (Weeks 1-4): 56 mg or 84 mg twice weekly.
- Maintenance Phase (Weeks 5-8): 56 mg or 84 mg once weekly.
- Long-Term Maintenance: 56 mg or 84 mg every one to two weeks, as needed.
Providers should tailor the dosage to the patient’s response and tolerance, ensuring optimal outcomes while minimizing risks.
What Drugs Interact with Esketamine (Spravato)?
Spravato can interact with other medications, potentially increasing the risk of side effects or reducing effectiveness. Key interactions include:
- Central Nervous System (CNS) Depressants: Combining Spravato with alcohol, benzodiazepines, or opioids can intensify sedation and dissociation.
- Monoamine Oxidase Inhibitors (MAOIs): Concurrent use may increase blood pressure.
Always review a patient’s medication history before prescribing Spravato and adjust treatments as necessary.
Is Esketamine (Spravato) Safe to Use While Pregnant or Breastfeeding?
The safety of Spravato during pregnancy or breastfeeding has not been thoroughly studied. Animal studies suggest potential risks to fetal development, so it’s generally recommended to avoid Spravato in these populations unless the benefits outweigh the risks. Providers should discuss alternative treatments with pregnant or breastfeeding patients and involve them in shared decision-making.
FAQs about Spravato, Side Effects, Use, Treatment, and Safety
Spravato targets the NMDA receptors in the brain, helping to restore synaptic connections and improve mood. It’s particularly effective for patients who haven’t responded to traditional antidepressants.
Spravato alleviates symptoms of treatment-resistant depression and reduces suicidal ideation in adults with MDD. It provides rapid relief compared to conventional antidepressants, often within hours or days.
While Spravato has a low potential for abuse, it must be administered in a controlled clinical setting to minimize risks. Providers should monitor patients for signs of misuse.
The duration varies by patient. Some may require ongoing maintenance doses, while others may transition to other treatments after significant improvement.
Yes, Spravato is often used alongside oral antidepressants to enhance its effectiveness.
Conclusion
Providing Spravato services requires a thorough understanding of the medication, its administration, and patient monitoring protocols. By staying informed and addressing patient concerns, mental health providers can offer this innovative treatment safely and effectively, helping patients achieve better mental health outcomes.
